Theratechnologies misses Q1 top-line and bottom-line estimates; updates FY25 outlook

featured-image

Theratechnologies press release ( NASDAQ: THTX ): Q1 GAAP EPS of $0.00 misses by $0.03 .

Revenue of $19.05M (+17.2% Y/Y) misses by $1.



38M . For the first quarter of Fiscal 2025, sales of EGRIFTA SV ® reached $13.88M compared to $9.

59M in the first quarter of.